Package 68001-511-06

Brand: QUETIAPINE FUMARATE

Generic: QUETIAPINE FUMARATE
NDC Package

Package Facts

Identity

Package NDC 68001-511-06
Digits Only 6800151106
Product NDC 68001-511
Product ID 68001-511_303ec748-0ce2-d2bb-e063-6394a90a5813
Description

60 TABLET, EXTENDED RELEASE in 1 BOTTLE (68001-511-06)

Marketing

Marketing Status
Discontinued 2026-02-28
Brand QUETIAPINE FUMARATE
Generic QUETIAPINE FUMARATE
Sample Package No

Linked Drug Pages (1)

QUETIAPINE FUMARATE ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "303ec748-0ce2-d2bb-e063-6394a90a5813", "openfda": {"unii": ["2S3PL1B6UJ"], "rxcui": ["853201"], "spl_set_id": ["529c41df-70e1-4f18-ad36-05e169fa0a07"], "manufacturer_name": ["Bluepoint Laboratories"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (68001-511-06)", "package_ndc": "68001-511-06", "marketing_end_date": "20260228", "marketing_start_date": "20210831"}], "brand_name": "QUETIAPINE FUMARATE", "product_id": "68001-511_303ec748-0ce2-d2bb-e063-6394a90a5813", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Atypical Antipsychotic [EPC]"], "product_ndc": "68001-511", "generic_name": "QUETIAPINE FUMARATE", "labeler_name": "Bluepoint Laboratories", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "QUETIAPINE FUMARATE", "active_ingredients": [{"name": "QUETIAPINE FUMARATE", "strength": "50 mg/1"}], "application_number": "ANDA206252", "marketing_category": "ANDA", "marketing_end_date": "20260228", "marketing_start_date": "20210831"}